Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Competing interests The authors declare that there is no conflict of interest
Professional Support for Weight Management Programs Sometimes, your doctor might recommend a more structured weight management program
GRADE Working Group
Diabetes medicines may require clinician-directed adjustment and glucose monitoring
SARC031: A Phase 2 Trial of the MEK Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Combination with the mTOR Inhibitor Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors PI: AeRang Kim, M.D., Ph.D
.png/:/cr=t:1.02%25,l:0%25,w:100%25,h:94.27%25/rs=w:600,h:800,cg:true)
US$ 24.96
US$ 29.90
US$ 21.30
.webp)
US$ 26.66
